Novo Nordisk (NVO) declined to comment on when the company would end production of human insulin pens, adding that the pens were different from those used for its hugely popular GLP-1 drugs ...

Novo has signed new partnership agreements with Dexcom, Glooko, and Roche, all of whom have technology that allows the Danish pharma to steal a march with its competitors with the launch of its ...

A Cornerstone in Diabetes ManagementInsulin delivery devices market are innovative medical instruments designed to provide ...

Counterfeit Ozempic-labelled pens thought to contain a different medication have been caught being imported into Australia, ...

A doctor and honorary researcher at the University of Exeter is leading a campaign to make reusable insulin pens the standard for treating diabetes patients. Dr Vincent Simpson aims to cut down on ...

Learn more As my family prepared recently for our first big vacation in several years, we ran into a problem: How would we keep my dad's insulin pens cold enough to avoid spoiling until we reached ...

NovoPen ®, the first insulin pen injector, was introduced in 1985. This article reviews the published evidence over two decades of use of the NovoPen ® family of injection devices in diabetes ...

Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp up manufacturing of its popular obesity and diabetes injections. The ...

Dr Vincent Simpson aims to reduce plastic waste and save the NHS money by championing reusable insulin pens A doctor and honorary researcher at the University of Exeter is leading a campaign to ...